To better understand the stage(s) of differentiation reached by B-type chronic lymphocytic leukemia (B-CLL) cells and to gain insight into the potential role of antigenic stimulation in the development and diversification of these cells, we analyzed the rearranged VH genes expressed by 83 B-CLL cells (64 IgM+ and 19 non-IgM+). Our results confirm and extend the observations of a bias in the use of certain VH, D, and JH genes among B-CLL cells. In addition, they indicate that the VH genes of approximately 50% of the IgM+ B-CLL cells and approximately 75% of the non-IgM+ B-CLL cells can exhibit somatic mutations. The presence of mutation varies according to the VH family expressed by the B-CLL cell (VH3 expressers displaying more mutation than VH1 and VH4 expressers). In addition, the extent of mutation can be sizeable with approximately 32% of the IgM+ cases and approximately 68% of the non-IgM+ cases differing by > 5% from the most similar germline gene. Approximately 20% of the mutated VH genes display replacement mutations in a pattern consistent with antigen selection. However, CDR3 characteristics (D and JH gene use and association and HCDR3 length, composition, and charge) suggest that selection for distinct B cell receptors (BCR) occurs in many more B-CLL cells. Based on these data, we suggest three prototypic BCR, representing the VH genes most frequently encountered in our study. These data suggest that many B-CLL cells have been previously stimulated, placing them in the "experienced" or "memory" CD5(+) B cell subset.
F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, S L Allen, P Schulman, V P Vinciguerra, K Rai, L Z Rassenti, T J Kipps, G Dighiero, H W Schroeder Jr, M Ferrarini, N Chiorazzi
Title and authors | Publication | Year |
---|---|---|
A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies
AL Myhrinder, E Hellqvist, E Sidorova, A Soderberg, H Baxendale, C Dahle, K Willander, G Tobin, E Backman, O Soderberg, R Rosenquist, S Horkko, A Rosen |
Blood | 2008 |
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA
CC Chu, R Catera, K Hatzi, XJ Yan, L Zhang, XB Wang, HM Fales, SL Allen, JE Kolitz, KR Rai, N Chiorazzi |
Blood | 2008 |
Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3
GF 2nd, CJ Goldberg, TL Toy, LZ Rassenti, WG Wierda, JC Byrd, MJ Keating, JG Gribben, KR Rai, TJ Kipps |
Blood | 2008 |
Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia
A Hadzidimitriou, N Darzentas, F Murray, T Smilevska, E Arvaniti, C Tresoldi, A Tsaftaris, N Laoutaris, A Anagnostopoulos, F Davi, P Ghia, R Rosenquist, K Stamatopoulos, C Belessi |
Blood | 2008 |
Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Oxidation
R Catera, GJ Silverman, K Hatzi, T Seiler, S Didier, L Zhang, M Hervé, E Meffre, DG Oscier, H Vlassara, RH Scofield, Y Chen, SL Allen, J Kolitz, KR Rai, CC Chu, N Chiorazzi |
Molecular Medicine | 2008 |
Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation
P Ghia, N Chiorazzi, K Stamatopoulos |
Journal of Internal Medicine | 2008 |
Farnesyl transferase inhibitors induce extended remissions in transgenic mice with mature B cell lymphomas
KA Field, S Charoenthongtrakul, JM Bishop, Y Refaeli |
Molecular Cancer | 2008 |
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia
FJ Li, S Ding, J Pan, MA Shakhmatov, E Kashentseva, J Wu, Y Li, S Soong, N Chiorazzi, RS Davis |
Blood | 2008 |
Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters
V Jurisic, N Colovic, N Kraguljac, HD Atkinson, M Colovic |
Medical Oncology | 2008 |
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
KI Lin, CS Tam, MJ Keating, WG Wierda, S O'Brien, S Lerner, KR Coombes, E Schlette, A Ferrajoli, LL Barron, TJ Kipps, L Rassenti, S Faderl, H Kantarjian, LV Abruzzo |
Blood | 2008 |
Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients
T Butler, JG Gribben |
Expert Opinion on Medical Diagnostics | 2008 |
Chronic lymphocytic leukaemia: An immunobiology approach
E Kostareli, T Smilevska, K Stamatopoulos, A Kouvatsi, A Anagnostopoulos |
Srpski arhiv za celokupno lekarstvo | 2008 |
Chronic lymphocytic leukemia patients exposed to ionizing radiation due to the Chernobyl NPP accident—With focus on immunoglobulin heavy chain gene analysis
I Abramenko, N Bilous, A Chumak, E Davidova, I Kryachok, Z Martina, S Nechaev, I Dyagil, D Bazyka, V Bebeshko |
Leukemia Research | 2008 |
MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis
YO Huh, KI Lin, F Vega, E Schlette, CC Yin, MJ Keating, R Luthra, LJ Medeiros, LV Abruzzo |
British Journal of Haematology | 2008 |
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome
D Rossi, M Cerri, D Capello, C Deambrogi, FM Rossi, A Zucchetto, LD Paoli, S Cresta, S Rasi, V Spina, S Franceschetti, M Lunghi, C Vendramin, R Bomben, A Ramponi, G Monga, A Conconi, C Magnani, V Gattei, G Gaidano |
British Journal of Haematology | 2008 |
Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia
M Hojjat-Farsangi, M Jeddi-Tehrani, AA Amirzargar, SM Razavi, RA Sharifian, H Rabbani, F Shokri |
Human Immunology | 2008 |
Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia
L Chen, Y Zhang, W Zheng, Y Wu, C Qiao, L Fan, W Xu, J Li |
Leukemia Research | 2008 |
Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabinein vitro
L Amrein, TA Hernandez, C Ferrario, J Johnston, SB Gibson, L Panasci, R Aloyz |
British Journal of Haematology | 2008 |
Molecular Profiling in CLL
JG Gribben |
Hematology | 2008 |
Molecular genetic characterization reveals new subsets of mantle cell lymphoma
EF Thelander, R Rosenquist |
Leukemia & Lymphoma | 2008 |
Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: A randomized phase II study from the Nordic Lymphoma Group
E Kimby, J Jurlander, C Geisler, H Hagberg, H Holte, T Lehtinen, B Östenstad, M Hansen, A Österborg, O Lindén, C Sundström, OB Gr |
Leukemia & Lymphoma | 2008 |
Mutated IgHV1-69 gene usage represents a distinct subgroup associated with indolent disease in chronic lymphocytic leukemia
L Galligan, MA Catherwood, C Matthews, TC Morris, HD Alexander |
Leukemia & Lymphoma | 2008 |
Chronic lymphocytic leukemia with mutated IgVH1-69 usage: A distinct CLL subgroup with more indolent behavior?
EM Hartmann, A Rosenwald |
Leukemia & Lymphoma | 2008 |
Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia
S Fabris, L Mosca, K Todoerti, G Cutrona, M Lionetti, D Intini, S Matis, M Colombo, L Agnelli, M Gentile, M Spriano, V Callea, G Festini, S Molica, GL Deliliers, F Morabito, M Ferrarini, A Neri |
Genes, Chromosomes and Cancer | 2008 |
Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia
AC Rawstron, FL Bennett, SJ O'Connor, M Kwok, JA Fenton, M Plummer, R Tute, RG Owen, SJ Richards, AS Jack, P Hillmen |
New England Journal of Medicine | 2008 |
Hematopathology
F Naeim |
Hematopathology | 2008 |
Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA)
V Grubor, A Krasnitz, JE Troge, JL Meth, B Lakshmi, JT Kendall, B Yamrom, G Alex, D Pai, N Navin, LA Hufnagel, YH Lee, K Cook, SL Allen, KR Rai, RN Damle, C Calissano, N Chiorazzi, M Wigler, D Esposito |
Blood | 2008 |
Chronic Lymphocytic Leukemia: The Role of MBL
P Ghia, A Rawstron |
Chronic Lymphocytic Leukemia: The Role of MBL | 2008 |
Use of V H, D and J H immunoglobulin gene segments in Brazilian patients with chronic lymphocytic leukaemia (CLL)
BJ Pimentel, CG Stefanoff, AS Moreira, HN Seuánez, IR Zalcberg |
Genetics and molecular biology | 2008 |
Molecular Genetic Pathology
L Cheng, DY Zhang |
2008 |